Literature DB >> 14751758

Endotoxin recognition molecules, Toll-like receptor 4-MD-2.

Kensuke Miyake1.   

Abstract

Toll-like receptors (TLRs) are innate pathogen recognition molecules for microbial products. Lipopolysaccharide (LPS), a membrane constituent of Gram-negative bacteria, is one of the most potent microbial products. LPS is recognized by TLR4 and MD-2. TLR4 is a transmembrane protein, the extracellular domain of which is composed of a protein motif called leucine-rich repeats (LRR). MD-2 is an extracellular molecule that is associated with the extracellular LRR of TLR4. MD-2 has a role in cell surface expression of TLR4 and interaction with LPS. TLR4-MD-2 contributes to containment of infections by Gram-negative bacteria by activating immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751758     DOI: 10.1016/j.smim.2003.10.007

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  31 in total

1.  ß-adrenergic stimulation increases macrophage CD14 expression and E. coli phagocytosis through PKA signaling mechanisms.

Authors:  Kuzhali Muthu; Li-K He; Andrea Szilagyi; Patrick Strotmon; Richard L Gamelli; Ravi Shankar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

2.  The tobacco smoke component acrolein induces glucocorticoid resistant gene expression via inhibition of histone deacetylase.

Authors:  Matthew J Randall; Guido R M M Haenen; Freek G Bouwman; Albert van der Vliet; Aalt Bast
Journal:  Toxicol Lett       Date:  2015-10-19       Impact factor: 4.372

3.  GATA factors participate in tissue-specific immune responses in Drosophila larvae.

Authors:  Kate Senger; Kristina Harris; Mike Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-10       Impact factor: 11.205

4.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 5.  The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.

Authors:  Huan Yang; Daniel J Antoine; Ulf Andersson; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2013-02-27       Impact factor: 4.962

6.  Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.

Authors:  Timea Csak; Arumugam Velayudham; Istvan Hritz; Jan Petrasek; Ivan Levin; Dora Lippai; Donna Catalano; Pranoti Mandrekar; Angela Dolganiuc; Evelyn Kurt-Jones; Gyongyi Szabo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-13       Impact factor: 4.052

7.  Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria.

Authors:  Koji Nagaoka; Kazuhiko Takahara; Kay Tanaka; Hideo Yoshida; Ralph M Steinman; Shin-Ichiro Saitoh; Sachiko Akashi-Takamura; Kensuke Miyake; Young Sun Kang; Chae Gyu Park; Kayo Inaba
Journal:  Int Immunol       Date:  2005-05-20       Impact factor: 4.823

8.  Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2.

Authors:  Jozica Vasl; Alja Oblak; Theresa L Gioannini; Jerrold P Weiss; Roman Jerala
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

9.  Structure and immunogenicity of the rough-type lipopolysaccharide from the periodontal pathogen Tannerella forsythia.

Authors:  Gerald Posch; Oleh Andrukhov; Evgeny Vinogradov; Buko Lindner; Paul Messner; Otto Holst; Christina Schäffer
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

10.  TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide.

Authors:  Yuji Kondo; Kazutaka Ikeda; Noriyo Tokuda; Chiaki Nishitani; Umeharu Ohto; Sachiko Akashi-Takamura; Yasutomo Ito; Makoto Uchikawa; Yoshio Kuroki; Ryo Taguchi; Kensuke Miyake; Qing Zhang; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.